TNFAIP3-Interacting Protein 1 (TNIP1) Antibody

Interacts with zinc finger protein A20/TNFAIP3 and inhibits TNF-induced NF-kappa-B-dependent gene expression by interfering with an RIP-or TRAF2-mediated transactivation signal (By similarity). Increases cell surface CD4 (T4) antigen expression. Interacts with HIV-1 matrix protein and is packaged into virions and overexpression can inhibit viral replication. May regulate matrix nuclear localization, both nuclear import of PIC (Preintegration complex) and export of GAG polyprotein and viral genomic RNA during virion production.

Target	TNFAIP3-Interacting Protein 1 (TNIP1)
Clonality	Polyclonal
Reactivity	Human
Tested Applications	ELISA, WB
Host	Rabbit
Recommended dilutions	WB: 1/1000. Optimal dilutions/concentrations should be determined by the end user.
Conjugation	Unconjugated
Immunogen	KLH-conjugated synthetic peptide between 607-636 amino acids from the C-terminal region of human TNIP1.
Isotype	IgG
Form	Liquid
Purification	Purified through a protein A column, followed by peptide affinity purification.
Storage	Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC	Q15025 (UniProt, ExPASy)
UniProt Entry Name	TNIP1_HUMAN
KEGG	hsa:10318
String	9606.ENSP00000317891
Molecular Weight	Calculated MW: 71.9 kDa
Buffer	PBS containing 0.09% sodium azide.
Availability	Shipped within 5-10 working days.
Note	This product is for research use only.

Research Articles on TNFAIP3-Interacting Protein 1 (TNIP1)

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue